To investigate whether the JNK pathway may control TRAIL-induced apoptosis of colon cancer cells, phosphorylation of JNK was first assessed by immunoblotting following treatment with rhTRAIL, sunitinib, and the combination. The gene discussed is MAPK8; the disease is colonic neoplasm.